Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARVN · against 434 other Healthcare companies of similar size
Ranked #252 of 435 · scores higher than 41% of peers
Bars: peers in each 10-point band of the profitability score60 peers with a profitability score of 30–39, including ARVN · Click a bar to see the companies
Mainly because of its operating margin and return on invested capital, which are weaker than most Healthcare peers.
| Metric | ARVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 404 reported | -3.1% | 1.7% | 38% | 33% | |
| Operating marginHigher is better · 408 reported | -5.7% | 4.2% | 33% | 33% | |
| Return on assetsHigher is better · 434 reported | 1.3% | 0.9% | 55% | 33% | |
| Return on equityHigher is better · 414 reported | 1.6% | 0.7% | 53% | Context only | |
| Gross marginHigher is better · 454 reported | 97.2% | 39.6% | 96% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 245 | 500M USD | 37 | 63 | |
| 252 | 3.7B CNY (≈$517M) | 36 | 24 | |
| 252 | 2.0B CNY (≈$284M) | 36 | 34 | |
| 252 | 2.1B CNY (≈$295M) | 36 | 39 | |
| 252 | 457M USD | 36 | 58 | |
| 256 | 2.9B HKD (≈$366M) | 35 | 47 | |
| 256 | 62.7B JPY (≈$426M) | 35 | 40 | |
| 256 | 356M USD | 35 | 35 | |
| 256 | 471M NZD (≈$282M) | 35 | 23 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score